Latest News & Features
Americas
The US Food and Drug Administration’s generic drug approval rate has increased at a “rapid rate” since January 2017, despite the number of branded drug patent expirations declining during this period. 26 October 2018
Americas
More than 500 tonnes of illicit pharmaceuticals have been seized worldwide as part of a global operation led by Interpol, as announced on Tuesday. 26 October 2018
Americas
With several major drugs set to face generic or biosimilar competition as patent protection expires, LSIPR analyses how well prepared their manufacturers are and how badly their sales may be affected. 26 October 2018
Americas
Siew Yen Chong has joined Nelson Mullins Riley & Scarborough’s New York office as of counsel. 26 October 2018
Americas
The US International Trade Commission yesterday announced that it will review in-part the final initial determination of an investigation into Fujifilm involving X-ray breast imaging. 25 October 2018
Americas
Duane Morris has appointed Patrick Gallagher as chair of the firm’s pharmaceuticals and biopharmaceuticals litigation and regulatory practice group. 25 October 2018
Big Pharma
Trademarks covering Bayer’s branded Aspirin were at the centre of an appeal dismissed by the EU General Court yesterday. 25 October 2018
Europe
The Munich District Court in Germany has found that sleep masks produced by Fisher & Paykel Healthcare infringe a European patent owned by ResMed. 24 October 2018
Americas
The US Federal Trade Commission yesterday said that Teva Pharmaceuticals has asked the commission to reopen and modify its decision and order regarding the 2012 merger of Actavis and Watson Pharmaceuticals. 24 October 2018
Americas
While cannabis companies in the US can’t protect their brands with federal trademark protection, there are other options for them when seeking IP rights, as LSIPR finds out. 24 October 2018